Aligos Therapeutics Alternatives & Competitors
12 companies similar to Aligos Therapeutics — Improving patient outcomes through best-in-class therapies for liver and viral d...
Companies similar to Aligos Therapeutics
Antios Therapeutics
Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing th...
Atlanta, United States
GENFIT
Dedicated to improving the lives of patients with liver diseases characterized by high unm...
Loos, France
89bio
Developing and commercializing innovative therapies for the treatment of liver and cardio-...
San Francisco, United Sta...
HighTide Therapeutics
East Meets West—The Quest for Cure
Shenzhen, China
Track all Aligos Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
CymaBay Therapeutics
Dedicated to improving the lives of patients with liver diseases
Newark, United States
Replicor Inc.
292 million people have chronic hepatitis B. We're developing the cure.
Montreal, Canada
-logo.jpg "Entero Therapeutics (Nasdaq: ENTO)"){kind=logo}
Entero Therapeutics (Nasdaq: ENTO)
A biopharma company focused on the development of targeted, non-systemic therapies for gas...
Boca Raton, United States
Hepion Pharmaceuticals
Hepion Pharmaceuticals, Inc. is not affiliated in any way with Wire™ or Wire Swiss GmbH in...
Edison, United States
Atea Pharmaceuticals, Inc
Discovery & development of breakthrough therapies for COVID-19 patients and severe viral d...
Boston, United States
Kinarus Therapeutics
Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respirato...
Basel, Switzerland
Creative BioTherapeutics LLC
An emerging biotech discovering & developing novel therapies for cancer and viruses where...
Gurnee, United States
Benitec Biopharma Inc.
Silencing genes for life
Hayward, United States
About Aligos Therapeutics
Aligos Therapeutics is a biopharmaceutical company founded in 2018 and headquartered in the United States. The company is focused on developing targeted therapeutics to address unmet medical needs in liver and viral diseases, including nonalcoholic steatohepatitis (MASH), chronic hepatitis B (CHB), and even COVID-19. A...
Biopharmaceutical Company, Therapeutics, Liver Diseases, Viral Infections, Clinical Stage, Antiviral Therapies, Chronic Hepatitis B, Coronaviruses, Drug Development, NASH, Targeted Therapies, Viral Hepatitis, MASH, CHB, COVID-19
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Aligos Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Aligos Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
